Advertisement

KURE Holdings Information

Compare
Holdings Count
50
Total Assets
98.05M
Top 10 Percentage
53.81%
Asset Class
Equity
Category
Sector
Region
Asia-Pacific
See the full list of holdings, find out what stocks are the most undervalued and get access to the all ETF's smart score and filters.Go Premium
50 Holdings as of Nov 14, 2025
50 Holdings as of Nov 14, 2025
Name
Weight %
Market Value
Price & Change
Market Cap
Yearly Gain
Analyst Consensus
Analyst Price Target
Smart Score
Follow
BeiGene Ltd
10.62%
$10.62M
HK$324.36B
91.75%
13 Buy
0 Hold
0 Sell
Strong Buy
Innovent Biologics
7.24%
$7.24M
$20.33B
126.73%
20 Buy
1 Hold
0 Sell
Strong Buy
600276
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A
7.09%
$7.09M
Wuxi Biologics (Cayman)
6.42%
$6.41M
$17.56B
133.16%
12 Buy
4 Hold
1 Sell
Moderate Buy
Sino Biopharmaceutical
4.32%
$4.32M
$16.88B
120.99%
16 Buy
1 Hold
0 Sell
Strong Buy
300760
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Class A
4.04%
$4.04M
603259
WuXi AppTec Co., Ltd. Class A
4.03%
$4.02M
3SBio, Inc.
3.83%
$3.83M
$10.75B
391.89%
10 Buy
1 Hold
0 Sell
Strong Buy
Akeso, Inc.
3.44%
$3.44M
HK$109.43B
72.80%
14 Buy
0 Hold
0 Sell
Strong Buy
Hansoh Pharmaceutical Group Company Limited
2.79%
$2.79M
HK$238.21B
130.33%
16 Buy
1 Hold
0 Sell
Strong Buy
Rows:
10

KURE ETF FAQ

What are ETF KURE’s top 3 holdings?
KURE’s top 3 holdings are HK:6160, HK:1801, CN:600276.
    What is ETF KURE’s holdings count?
    ETF KURE’s is holdings 50 different assets.
      What are the total assets of ETF KURE?
      ETF KURE’s total assets are 98.05M.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Advertisement